Display options
Share it on

PLoS One. 2021 Dec 15;16(12):e0261440. doi: 10.1371/journal.pone.0261440. eCollection 2021.

Sex differences in serum levels of 5α-androstane-3β, 17β-diol, and androstenediol in the young adults: A liquid chromatography-tandem mass spectrometry study.

PloS one

Haruka Tanabe, Hitoshi Mutai, Daimei Sasayama, Hidehiko Sasamoto, Yoshimichi Miyashiro, Nobuhiro Sugiyama, Shinsuke Washizuka

Affiliations

  1. Department of Medical Sciences, Graduate School of Medicine, Science and Technology, Shinshu University, Matsumoto, Nagano, Japan.
  2. Department of Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
  3. Division of Health Sciences, Department of Medical Sciences, Graduate School of Medicine, Shinshu University, Matsumoto, Nagano, Japan.
  4. Mental Health Clinic for Children, Shinshu University Hospital, Matsumoto, Nagano, Japan.
  5. Child and Adolescent Developmental Psychiatry, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
  6. ASUKA Pharma Medical Co., Ltd. Shonan Health Innovation Park, Fujisawa, Kanagawa, Japan.
  7. Department of Applied Occupational Therapy, Shinshu University School of Health Sciences, Matsumoto, Nagano, Japan.

PMID: 34910781 PMCID: PMC8673626 DOI: 10.1371/journal.pone.0261440

Abstract

Animal experiments have consistently shown that estrogen receptor β (ERβ)-selective ligands have antidepressant and anxiolytic effects. In humans, endogenous ligands for ERβ include 5α-androstane-3β, 17β-diol (3βAdiol) and androstenediol (Δ5-diol). We determined, for the first time, the exact serum levels of 3βAdiol and Δ5-diol in young healthy volunteers using liquid chromatography-tandem mass spectrometry (LC-MS/MS). We investigated the effect of the menstrual cycle on the levels of these steroids in women; then, we performed a gender comparison. Blood samples were collected from 48 subjects: 23 women (mean age = 28.4±7.8 years) and 25 men (mean age = 31.4±7.8 years). We collected the blood samples of women at three time-points in the menstrual cycle: the early follicular phase, ovulatory or mid-cycle phase, and mid-luteal phase. A total of 92 blood samples were analyzed using LC-MS/MS. The levels of two well-studied steroids, namely dehydroepiandrosterone (DHEA) and 17β-estradiol (E2), were simultaneously measured. Depression rating scale (Hamilton Rating Scale for Depression, Beck Depression Inventory-II and Quick Inventory of Depressive Symptomatology) scores were also recorded at the time of blood sampling. Significant differences in the levels of 3βAdiol and E2 and in the depression rating scale scores were observed over the duration of the menstrual cycle of the women. The levels of 3βAdiol and Δ5-diol were significantly lower in women than in men. E2 levels were higher in women than in men, and DHEA levels did not differ significantly between men and women. Further, women had higher scores than men on the Hamilton Rating Scale for Depression. Sex differences in depressive symptoms can be explained by 3βAdiol and Δ5-diol levels, and the effect of the menstrual cycle on mood can be explained by 3βAdiol and E2 levels, not by Δ5-diol level.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

  1. Horm Behav. 2008 Nov;54(5):726-34 - PubMed
  2. Biol Psychiatry. 2003 Sep 1;54(5):573-83 - PubMed
  3. Sci Rep. 2018 Feb 12;8(1):2861 - PubMed
  4. N Engl J Med. 2010 Jul 8;363(2):123-35 - PubMed
  5. Eur J Endocrinol. 2004 Sep;151(3):355-60 - PubMed
  6. Psychiatry Res. 2002 Jul 31;110(3):291-9 - PubMed
  7. J Pers Assess. 1996 Dec;67(3):588-97 - PubMed
  8. Am J Physiol Regul Integr Comp Physiol. 2013 Dec;305(11):R1215-67 - PubMed
  9. Endocrinology. 2005 Jan;146(1):147-55 - PubMed
  10. Psychoneuroendocrinology. 2003 Oct;28(7):863-74 - PubMed
  11. Trends Endocrinol Metab. 2010 Sep;21(9):545-52 - PubMed
  12. J Clin Endocrinol Metab. 2013 Apr;98(4):1376-87 - PubMed
  13. Horm Behav. 2008 May;53(5):741-52 - PubMed
  14. Sci Rep. 2017 Jul 5;7(1):4663 - PubMed
  15. Sci Rep. 2016 May 11;6:25878 - PubMed
  16. Cell. 2011 May 13;145(4):584-95 - PubMed
  17. Neuropharmacology. 2008 Jun;54(8):1233-8 - PubMed
  18. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 - PubMed
  19. Clin Chim Acta. 2017 Jul;470:115-124 - PubMed
  20. Endocrinology. 1997 Mar;138(3):863-70 - PubMed
  21. NCHS Data Brief. 2018 Feb;(303):1-8 - PubMed
  22. J Clin Endocrinol Metab. 2020 Mar 1;105(3): - PubMed
  23. Mol Psychiatry. 2009 Feb;14(2):223-32, 117 - PubMed
  24. Mol Psychiatry. 2013 Jun;18(6):674-80 - PubMed

Publication Types